Implantable biosensor and methods of use thereof

• US 9,357,952 B2
• Filed: 09/23/2013
• Issued: 06/07/2016
• Est. Priority Date: 12/18/2003
• Status: Active Grant

• Current Assignee: Metronom Health Inc.
• Original Assignee: Metronom Health Inc.
• Inventors: Botvinick, Elliot, Bremer, Troy M.
• Primary Examiner(s): TSAY, MARSHA M
• Application Number:
  US14/034,218
• Publication Number:
  US 20140163345A1
• Time in Patent Office: 988 Days
• Field of Search: 600345-347, 600/357, 600/360, 600/365, 205/778, 205/782.5, 205/792, 435/4, 435/14
• US Class Current: 1/1
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence
• CPC Class Codes: A61B 5/1473 invasive, e.g. introduced into the body by a catheter A61B5/1482 takes precedence
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes

Abstract

Provided herein is a stabilized oxygen transport matrix that includes a reversible oxygen binding protein, such as hemoglobin, immobilized throughout the stabilized oxygen transport matrix. The stabilized oxygen transport matrix is used to transport oxygen and can be used as an oxygen transport region and a reaction region of an analyte sensor, such as an implantable glucose sensor. The reversible binding protein can also function as an oxygen probe within the analyte sensor.

Claims

1. A sensor for measuring an analyte, the sensor comprising:

an oxygen transport region comprising at least one reversible oxygen binding protein;

an analyte reaction region, the analyte reaction region comprising;

an oxygen-permeable surface in communication with the oxygen transport region;

an analyte-permeable surface configured to allow a target analyte to pass through, the analyte-permeable surface located generally orthogonal to the oxygen-permeable surface; and

an analyte reaction chamber at least partially surrounded by the oxygen-permeable surface and the analyte-permeable surface, the reaction chamber configured to retain a target analyte oxidase enzyme;

wherein the oxygen-permeable surface, the analyte-permeable surface, and the analyte reaction chamber are configured to form an oxygen gradient in the analyte reaction region; and

a sensing region comprising at least one detector, wherein the detector is configured to spatially sample the oxygen gradient within the analyte reaction region.

2. The sensor of claim 1, wherein the analyte-permeable surface is smaller than the oxygen-permeable surface.

3. The sensor of claim 1, wherein the sensor is substantially non-oxygen consuming.

4. The sensor of claim 1, wherein the oxygen transport region comprises a hemeprotein, or an engineered heme derivative.

5. The sensor of claim 1, wherein the target analyte is selected from the group consisting of glucose, galactose, lactose, peroxide, cholesterol, amino acids, alcohol, lactic acid and mixtures thereof.

6. The sensor of claim 1, wherein the analyte passes through the analyte-permeable surface from a first portion to a second portion and the oxygen gradient has more oxygen near the second portion than the first portion.

7. The sensor of claim 1, wherein the oxygen gradient is dependent on analyte and target analyte oxidase levels.

8. The sensor of claim 1, wherein the analyte reaction region further comprises a reference region, wherein analyte concentration in the reference region is sufficiently low so as not to measurably reduce oxygen concentration in the reference region.

9. The sensor of claim 8, wherein the analyte passes through the analyte-permeable surface from a first portion to a second portion and the reference region is located after the second portion, so that the second portion is located between the first portion and the reference region.

10. The sensor of claim 9, wherein a size of the reference region depends on a reaction rate of glucose near the first portion.

11. The sensor of claim 8, wherein the reference region provides an analyte insensitive oxygen reference concentration.

12. The sensor of claim 8, wherein the at least one detector is configured to measure oxygen concentration in the reference region.

13. The sensor of claim 1, wherein the sensor is configured to be a transcutaneous sensor.

14. The sensor of claim 1, wherein the analyte is glucose.

15. The sensor of claim 1, wherein the sensor is implanted in subcutaneous tissue.